PUNITHA KRISHNASAMY: Open Payments
NPI 1447731112 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,392 in 48 payments from 10 companies in 2025. Trend: 2023 $1,355 · 2024 $1,500 · 2025 $4,392
Food & beverage: $1,794Consulting: $1,388Travel & lodging: $1,210
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $3,034 |
| Neurocrine BioSciences, Inc. | 9 | $311 |
| Otsuka America Pharmaceutical, Inc. | 5 | $308 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $240 |
| Teva Pharmaceuticals USA, Inc. | 6 | $235 |
| ABBVIE INC. | 1 | $125 |
| Alkermes, Inc. | 3 | $52 |
| Lundbeck LLC | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: REXULTI, INGREZZA, CAPLYTA, COBENFY, UZEDY, VRAYLAR, AUSTEDO XR, ARISTADA.
Industry payments across TX — which companies pay providers there.
